SEC13 Human

SEC13 Human Recombinant
Shipped with Ice Packs
In Stock

Description

COPII Vesicle Trafficking

As a core component of the COPII complex, SEC13 interacts with Sec31A to form the outer layer of vesicles mediating ER-to-Golgi transport . Key findings include:

  • Cargo Selection: Regulates export of proteins like CFTR. Silencing SEC13 stabilizes CFTR, reducing degradation and improving ER exit .

  • ER Stress Response: Required for proper ER-Golgi intermediate compartment (ERGIC) recycling and degradation pathways .

Nuclear Pore Complex (NPC) Assembly

SEC13 integrates into NPCs to facilitate nucleo-cytoplasmic transport. Studies reveal:

  • NPC Dynamics: Shuttles between cytoplasmic and nuclear pools via active transport, with a nuclear localization signal (NLS) .

  • NPC Stability: Mutations disrupting NPC function (e.g., nup107 in zebrafish) phenocopy SEC13-related retinal defects, emphasizing its NPC-specific role .

Interactome and Regulatory Networks

SEC13 interacts with diverse complexes, as shown in human bronchial epithelial (HBE) cell studies:

Interaction PartnerComplex/FunctionImpact of SEC13 Silencing
Sec31ACOPII vesicle formationDisrupted ER-Golgi trafficking
Nup96, Nup98NPC assemblyRetinal lamination defects
GATOR2 (Mios, WDR24)mTORC1 nutrient sensing via lysosomesAltered autophagy-lysosomal pathways
Chromatin modifiersTranscriptional regulationDeregulates RNA maturation/degradation

Immunological Dysregulation

SEC13 H/− mice exhibit:

  • Reduced MHC I/II Expression: Impaired antigen presentation to T cells .

  • Cytokine Imbalance: Low IFN-γ/IL-6 and elevated TGF-β, indicative of a pro-immunosuppressive profile .

Disease-Associated Mutations

  • Neuropathies: Mutations in SEC13 or interacting WD-repeat proteins cause severe peripheral neuropathies .

  • Cystic Fibrosis (CFTR): SEC13 levels modulate CFTR stability, suggesting therapeutic potential in CF .

Antibody Detection

R&D Systems’ SEC13 antibody (AF9055) detects:

  • Western Blot: 37 kDa band in human kidney/lung lysates .

  • Immunofluorescence: Cytoplasmic and nuclear staining in HeLa cells .

Experimental Models

ModelObservationSource
ZebrafishNPC-specific retinal defects in sec13 sq198
Mouse (Sec13 H/−)Immune dysfunction, ER morphology intact

Product Specs

Introduction
SEC13, a member of the SEC13 family of WD-repeat proteins, is found in the endoplasmic reticulum and nuclear pore complex. Functionally similar to its yeast counterpart, SEC13 is crucial for vesicle formation from the endoplasmic reticulum during protein transport. It interacts with SEC31A and SEC31B, with SEC31A colocalizing with SEC13 in subcellular structures associated with vesicle transport, highlighting their role in COPII vesicle formation.
Description
Recombinant Human SEC13, expressed in E. coli, is a non-glycosylated polypeptide chain containing 342 amino acids (1-322 a.a.) with a 20 amino acid His tag at the N-terminus. This protein has a molecular weight of 37.7 kDa. The purification process involves proprietary chromatographic techniques, resulting in a single, purified protein.
Physical Appearance
Clear, colorless, and sterile-filtered solution.
Formulation
The SEC13 solution is provided at a concentration of 0.5 mg/ml in a buffer consisting of 20mM Tris-HCl (pH 8.0), 1mM DTT, 10% glycerol, and 100mM NaCl.
Stability
For short-term storage (2-4 weeks), the solution should be kept at 4°C. For extended storage, it is recommended to freeze the solution at -20°C. Adding a carrier protein (0.1% HSA or BSA) is recommended for long-term storage. Repeated freezing and thawing should be avoided.
Purity
The purity of SEC13 is greater than 95.0% as determined by SDS-PAGE analysis.
Synonyms

Protein SEC13 homolog, SEC13-like protein 1, SEC13-related protein, SEC13, D3S1231E, SEC13L1, SEC13R, npp-20.

Source
Escherichia Coli.
Amino Acid Sequence

MGSSHHHHHH SSGLVPRGSH MVSVINTVDT SHEDMIHDAQ MDYYGTRLAT CSSDRSVKIF DVRNGGQILI ADLRGHEGPV WQVAWAHPMY GNILASCSYD RKVIIWREEN GTWEKSHEHA GHDSSVNSVC WAPHDYGLIL ACGSSDGAIS LLTYTGEGQW EVKKINNAHT IGCNAVSWAP
AVVPGSLIDH PSGQKPNYIK RFASGGCDNL IKLWKEEEDG QWKEEQKLEA HSDWVRDVAW APSIGLPTST IASCSQDGRV FIWTCDDASS NTWSPKLLHK FNDVVWHVSW SITANILAVS GGDNKVTLWK ESVDGQWVCI SDVNKGQGSV SASVTEGQQN EQ.

Q&A

What is SEC13 and what is its primary function in human cells?

SEC13 functions as a critical component of the coat complex II (COPII) system, specifically serving as a cage assembly factor. Unlike many other trafficking proteins with singular functions, SEC13 serves as a master regulator coordinating information flow from the genome to the proteome to facilitate spatial covariant features in human cells . The protein's multifunctional capacity enables it to simultaneously participate in multiple cellular processes, from chromatin organization to protein trafficking. Research indicates that SEC13 is simultaneously associated with multiple protein complexes that facilitate different features of a continuous program including chromatin organization, transcription, translation, trafficking, and degradation steps .

How does SEC13 differ from other COPII components?

Unlike other COPII components, SEC13 demonstrates unique regulatory capabilities in protein trafficking and degradation pathways. Specifically, reduction of SEC13 expression decreases the ubiquitination and degradation of both wild-type and F508del variant cargo proteins such as cystic fibrosis transmembrane conductance regulator (CFTR) . This reduction leads to a striking increase in fold stability, suggesting that SEC13 critically influences the differentiation between export and degradation processes. This occurs primarily at the ER Golgi intermediate compartment (ERGIC) associated recycling and degradation step linked to COPI exchange . These distinct functions highlight SEC13's specialized role compared to other COPII components.

What key protein complexes is SEC13 associated with?

SEC13 demonstrates remarkable versatility in its protein interactions, associating simultaneously with multiple protein complexes that facilitate different aspects of cellular function. These include complexes involved in:

  • Chromatin organization

  • Transcriptional regulation

  • Translation processes

  • Protein trafficking mechanisms

  • Protein degradation pathways

Each of these associations is differentially sensitive to SEC13 levels, allowing SEC13 to function as a coordinator of information flow from the genome to the proteome . This wide-ranging association network positions SEC13 as a central hub in cellular information processing and protein management systems.

What are the standard methods for modulating SEC13 expression in experimental settings?

When designing experiments to study SEC13 function, researchers typically employ several approaches to modulate SEC13 expression:

RNA Interference (RNAi):

  • siRNA transfection targeting SEC13 mRNA

  • shRNA stable expression systems

  • CRISPR interference (CRISPRi) for transcriptional repression

Overexpression Systems:

  • Transient transfection with SEC13 expression vectors

  • Stable cell lines with inducible SEC13 expression

  • Viral delivery systems for hard-to-transfect cells

When modulating SEC13 expression, it is critical to monitor the differential effects on its multiple associated protein complexes, as research shows these complexes respond with varying sensitivity to changes in SEC13 levels . Quantitative western blotting coupled with co-immunoprecipitation assays can help determine the threshold levels at which different SEC13 functions are affected.

How can researchers effectively measure changes in protein trafficking associated with SEC13 manipulation?

To accurately measure changes in protein trafficking associated with SEC13 manipulation, researchers should employ a multi-faceted approach:

Quantitative Trafficking Assays:

  • Pulse-chase experiments with fluorescently labeled cargo proteins

  • Live-cell imaging with selective markers for COPII vesicles

  • RUSH (Retention Using Selective Hooks) system to synchronize cargo protein release

Molecular Analysis:

  • Ubiquitination analysis of cargo proteins such as CFTR

  • Protein stability measurements through cycloheximide chase experiments

  • Co-localization studies with markers of the ER, ERGIC, and Golgi compartments

Based on research findings, particular attention should be paid to the ERGIC-associated recycling and degradation step linked to COPI exchange, as this appears to be a critical point where SEC13 influences the decision between export and degradation of cargo proteins . When analyzing results, researchers should account for the multifunctional nature of SEC13 and ensure controls are in place to distinguish direct trafficking effects from secondary consequences related to its other cellular roles.

What model systems are most appropriate for studying SEC13 function?

The selection of appropriate model systems for SEC13 research depends on the specific aspects of its function being investigated:

Cellular Models:

Model TypeAdvantagesBest Applications
HEK293 cellsHighly transfectable, express many trafficking componentsInitial mechanistic studies, protein interaction analysis
Epithelial cell linesPolarized trafficking, physiologically relevantTransport of membrane proteins, spatial organization
Primary human cellsNative expression levels, physiological regulationValidation of findings from cell lines, disease relevance

Disease Models:

  • Cystic fibrosis cellular models expressing F508del CFTR mutation are particularly valuable, as SEC13 has demonstrated significant effects on CFTR stability when modulated

  • Patient-derived organoids can provide insights into SEC13's role in tissue-specific contexts

When selecting a model system, researchers should consider that SEC13's diverse functions may be differentially represented across cell types. Evidence suggests that SEC13 serves as a master regulator coordinating information flow from genome to proteome across various cellular compartments, so the ideal model system should maintain these regulatory networks intact .

How does SEC13 coordinate information flow from genome to proteome?

SEC13's role in coordinating information flow from genome to proteome involves a sophisticated network of interactions spanning multiple cellular compartments. This coordination occurs through:

Chromatin Association:
SEC13 participates in chromatin organization processes, potentially influencing gene accessibility and expression patterns that determine which proteins will be synthesized .

Transcriptional Coupling:
By associating with transcriptional machinery, SEC13 may help couple the process of gene expression to downstream events in the protein production pathway .

Translation-Trafficking Integration:
SEC13 simultaneously participates in protein synthesis and trafficking pathways, potentially serving as a feedback mechanism that adjusts translation rates based on trafficking capacity .

Compartmental Communication:
As a component of multiple protein complexes, SEC13 may facilitate communication between cellular compartments, ensuring coordinated responses to changes in cellular state or environmental conditions .

This multi-level involvement positions SEC13 as an integrator that helps maintain proteostasis by balancing production, trafficking, and degradation processes. The finding that different cellular processes show differential sensitivity to SEC13 levels suggests a mechanism by which cells can fine-tune their response to varying conditions through modulation of this single regulator .

What is the significance of SEC13's role in CFTR regulation for cystic fibrosis research?

SEC13's role in CFTR regulation has profound implications for cystic fibrosis research:

Enhanced Stability of Mutant CFTR:
Research has shown that reduction of SEC13 expression decreases the ubiquitination and degradation of both wild-type and F508del variant CFTR, leading to a striking increase in fold stability . This is particularly significant for the F508del mutation, which typically results in protein misfolding and enhanced degradation.

Potential Therapeutic Target:
The unique position of SEC13 at the intersection of trafficking and degradation pathways makes it a potential therapeutic target. By modulating SEC13 function or expression, it may be possible to shift the balance away from degradation toward successful trafficking of mutant CFTR to the plasma membrane.

Mechanistic Insights:
The finding that SEC13 critically influences the differentiation between export and degradation processes at the ERGIC provides new mechanistic insights into how cells make quality control decisions about membrane proteins . This understanding could inform the development of more targeted approaches to rescue mutant CFTR.

Broader Applications:
The principles learned from studying SEC13's role in CFTR regulation may extend to other membrane protein trafficking disorders, potentially expanding the therapeutic relevance beyond cystic fibrosis.

The research indicates that SEC13's effects on CFTR are linked to its role in COPII cage assembly particularly at the ERGIC-associated recycling and degradation step . This specificity offers a potential advantage for therapeutic interventions that could be designed to target this particular function of SEC13 without disrupting its other cellular roles.

How do variations in SEC13 expression influence cellular proteostasis?

Variations in SEC13 expression have multifaceted effects on cellular proteostasis due to SEC13's involvement in multiple protein complexes and cellular processes:

Differential Sensitivity:
Research indicates that different cellular processes exhibit varying degrees of sensitivity to SEC13 levels . This graduated response enables cells to prioritize certain functions when SEC13 availability is limited, potentially serving as an adaptive mechanism.

Trafficking-Degradation Balance:
Changes in SEC13 expression significantly impact the balance between protein trafficking and degradation. Specifically, reduction of SEC13 expression has been shown to decrease ubiquitination and degradation of certain cargo proteins, suggesting that modulation of SEC13 can shift the cellular preference between recycling and elimination of proteins .

Compartmental Organization:
SEC13's role in maintaining the architecture of cellular compartments means that alterations in its expression can influence the spatial organization of the endomembrane system. This has implications for the efficiency of protein trafficking and quality control mechanisms.

Stress Response Integration:
As a regulator coordinating information flow from genome to proteome, SEC13 likely plays a role in integrating stress responses across different cellular compartments. Changes in its expression may therefore affect the cell's ability to adapt to environmental challenges or internal perturbations.

The observation that SEC13 serves as an "unanticipated master regulator coordinating information flow from the genome to the proteome" suggests that its expression levels must be precisely controlled to maintain optimal proteostasis. Disruptions to this regulation could potentially contribute to diseases characterized by protein misfolding or trafficking defects.

What techniques are most effective for visualizing SEC13-dependent trafficking events?

Visualizing SEC13-dependent trafficking events requires specialized techniques that capture both the spatial and temporal aspects of this dynamic process:

Advanced Microscopy Approaches:

  • Super-resolution microscopy (STORM, PALM, or SIM) to resolve individual COPII vesicles and cage structures

  • Lattice light-sheet microscopy for extended live-cell imaging with reduced phototoxicity

  • Correlative light and electron microscopy (CLEM) to connect fluorescence signals with ultrastructural details

Molecular Probes and Reporters:

  • SEC13-fluorescent protein fusions (ensuring functionality is preserved)

  • Split fluorescent protein systems to detect SEC13 interactions with other COPII components

  • Cargo-specific reporters that change spectral properties upon trafficking progression

Quantitative Analysis Methods:

  • Automated tracking of vesicle formation and movement

  • Fluorescence recovery after photobleaching (FRAP) to measure assembly dynamics

  • Fluorescence correlation spectroscopy to analyze SEC13 molecular mobility

When implementing these techniques, special attention should be paid to the ERGIC compartment, as research has identified this as a critical site where SEC13-dependent decisions between export and degradation occur . Dual-color imaging with markers for both the COPII and COPI systems can help elucidate the hand-off between these coat complexes at the ERGIC, which appears to be particularly sensitive to SEC13 levels.

How should researchers design experiments to distinguish between SEC13's multiple cellular roles?

Designing experiments to distinguish between SEC13's multiple cellular roles requires careful planning and specialized approaches:

Domain-Specific Mutants:
Create SEC13 variants with mutations in specific functional domains to selectively disrupt individual roles while preserving others. This approach can help delineate which domains are essential for each cellular function.

Temporal Control Systems:

  • Rapid induction or degradation systems (e.g., auxin-inducible degron)

  • Optogenetic control of SEC13 recruitment to specific compartments

  • Temperature-sensitive variants to allow acute functional disruption

Compartment-Specific Analysis:

CompartmentAnalysis TechniqueKey Measurements
NucleusChIP-seq or CUT&RUNSEC13 chromatin association patterns
ER-to-GolgiVesicle budding assaysCOPII assembly kinetics
ERGICImmunoisolationCargo ubiquitination status
GlobalProteomicsDifferential protein complex association

Rescue Experiments:
Use targeted rescue approaches where SEC13 expression is restricted to specific compartments using localization signals. This can determine where SEC13 function is most critical for a given cellular process.

When interpreting results, researchers should consider that the effects seen after SEC13 manipulation may reflect the complex interplay between its multiple roles. The finding that SEC13 serves as a master regulator coordinating information flow across cellular compartments suggests that perturbations in one function might indirectly affect others through feedback mechanisms.

What are the key considerations when analyzing SEC13 interactome data?

Analyzing SEC13 interactome data requires specialized approaches to account for its multiple cellular roles and complex interaction network:

Data Collection Considerations:

  • Use multiple complementary techniques (affinity purification-MS, proximity labeling, Y2H screens)

  • Include appropriate controls for each cellular compartment where SEC13 functions

  • Consider native versus overexpression conditions carefully, as interaction patterns may differ

Analytical Framework:

  • Categorize interactions by cellular compartment and function

  • Assess interaction stability (transient vs. stable) through quantitative measures

  • Analyze condition-dependent interactions (e.g., stress, cell cycle phase)

Specialized Analytical Approaches:

  • Network analysis to identify interaction hubs and modules

  • Comparative interactomics across different expression levels of SEC13

  • Integration with functional data from genetic screens

Interpretation Guidelines:

  • Focus on interactions that explain SEC13's coordinating role between cellular processes

  • Look for protein complexes with differential sensitivity to SEC13 levels

  • Identify interactions at the ERGIC that might explain SEC13's role in determining cargo fate

Recent research has demonstrated that SEC13 is simultaneously associated with multiple protein complexes that facilitate different features of cellular processes from chromatin organization to protein degradation . When analyzing interactome data, special attention should be paid to interactions that connect these diverse functions, as these may represent key nodes in SEC13's role as a master regulator coordinating information flow from the genome to the proteome.

How can findings about SEC13 function be applied to understanding human disease mechanisms?

Findings about SEC13 function provide valuable insights into various human disease mechanisms:

Protein Trafficking Disorders:
SEC13's critical role in COPII cage assembly and its influence on the fate of cargo proteins like CFTR directly connects to diseases caused by protein trafficking defects. Research showing that reduction of SEC13 expression decreases ubiquitination and degradation of F508del CFTR provides a mechanistic link to cystic fibrosis pathophysiology.

Neurological Disorders:
Many neurodegenerative diseases involve protein misfolding and aggregation. SEC13's role in coordinating protein quality control decisions at the ERGIC may offer insights into why certain misfolded proteins escape degradation in these conditions.

Cancer Biology:
The coordination of information flow from genome to proteome by SEC13 may be relevant to understanding how cancer cells rewire their proteostasis networks to support altered growth patterns. Changes in SEC13 expression or function could potentially contribute to the altered protein trafficking seen in many cancer types.

Developmental Disorders:
Given SEC13's involvement in fundamental cellular processes, alterations in its function could contribute to developmental abnormalities. Its role in maintaining proper endomembrane architecture may be particularly relevant to understanding conditions affecting highly secretory cell types.

When investigating disease mechanisms related to SEC13, researchers should consider both direct effects on protein trafficking and the broader implications of disrupting a master regulator that coordinates multiple cellular processes . The differential sensitivity of various cellular functions to SEC13 levels suggests that even subtle changes in its expression could have complex, context-dependent effects on disease pathogenesis.

What therapeutic strategies might target SEC13-dependent pathways?

Several therapeutic strategies could potentially target SEC13-dependent pathways with precision:

Modulation of SEC13 Expression:

  • Antisense oligonucleotides or siRNA to partially reduce SEC13 levels

  • Small molecule enhancers of SEC13 expression for conditions requiring increased trafficking capacity

  • Targeted protein degradation approaches (PROTACs) for selective SEC13 reduction

Pathway-Specific Interventions:

Target PathwayTherapeutic ApproachPotential Applications
COPII cage assemblySmall molecules that modify SEC13 incorporation into the cageRescue of trafficking-deficient proteins
ERGIC quality controlModulators of the ERGIC-associated recycling stepReduction of excessive protein degradation
SEC13 protein interactionsPeptide mimetics that compete for specific binding sitesSelective disruption of disease-relevant interactions

Context-Dependent Approaches:
Given SEC13's role as a master regulator coordinating information flow from the genome to the proteome , therapeutic strategies might need to be context-dependent, targeting specific tissues or cellular states where intervention would be most beneficial.

Combinatorial Strategies:
For complex conditions like cystic fibrosis, combining SEC13-targeted approaches with existing therapies might yield synergistic benefits. For example, partially reducing SEC13 expression to decrease F508del CFTR degradation while simultaneously administering CFTR correctors could potentially enhance therapeutic efficacy.

When developing these strategies, careful consideration must be given to the potential consequences of disrupting SEC13's multiple functions. The observation that different cellular processes show differential sensitivity to SEC13 levels suggests the possibility of a therapeutic window where beneficial effects on one pathway could be achieved without significantly disrupting others.

How might variations in SEC13 contribute to individual differences in disease manifestation?

Variations in SEC13 may significantly contribute to individual differences in disease manifestation through several mechanisms:

Expression Level Variations:
Research has shown that different cellular processes exhibit differential sensitivity to SEC13 levels . Even subtle variations in SEC13 expression between individuals could therefore influence which cellular functions are preserved or compromised in disease states.

Genetic Modifiers:

  • Polymorphisms in SEC13 or its regulatory regions could alter its expression or function

  • Variations in SEC13-interacting proteins might modify its effects on specific pathways

  • Epigenetic differences affecting SEC13 expression could contribute to disease heterogeneity

Tissue-Specific Effects:
Because SEC13 coordinates processes from chromatin organization to protein degradation , its impact likely varies across tissue types depending on their specific proteostasis requirements. This could explain why certain diseases affect some tissues more severely than others despite involving proteins expressed throughout the body.

Environmental Interactions:
SEC13's role as a master regulator coordinating information flow from the genome to the proteome positions it as a potential mediator of gene-environment interactions. Individual variations in SEC13 function might influence how environmental stressors affect cellular proteostasis.

Therapeutic Response Prediction:
Understanding an individual's SEC13 status could potentially help predict their response to therapies targeting protein trafficking or degradation. For example, in cystic fibrosis, variations in SEC13 might influence the efficacy of treatments aimed at rescuing mutant CFTR from degradation.

When studying disease cohorts, researchers should consider incorporating SEC13 expression analysis and genetic profiling to identify potential correlations with disease severity or progression. The complex, multi-functional nature of SEC13 suggests that its contribution to disease heterogeneity may be equally multifaceted, requiring comprehensive assessment approaches.

What emerging technologies might advance our understanding of SEC13 function?

Several cutting-edge technologies hold promise for deepening our understanding of SEC13's complex cellular roles:

Spatially Resolved Omics:

  • Spatial transcriptomics to map SEC13-dependent gene expression patterns across cellular compartments

  • Spatial proteomics to track protein distribution changes in response to SEC13 modulation

  • In situ cryo-electron tomography to visualize native COPII cage structures at molecular resolution

Advanced Functional Genomics:

  • CRISPR base editing for precise modification of SEC13 regulatory elements

  • Single-cell multi-omics to correlate SEC13 expression with transcriptome, proteome, and cellular phenotypes

  • Perturb-seq approaches to systematically assess genetic interactions with SEC13

Artificial Intelligence Integration:

  • Deep learning analysis of SEC13-dependent vesicle dynamics

  • AI-assisted protein structure prediction to model SEC13 interactions

  • Machine learning classification of SEC13-dependent cellular phenotypes

Protein Engineering Approaches:

  • Optogenetic variants of SEC13 for spatiotemporal control of function

  • Engineered allosteric regulation of SEC13 activity

  • Biosensors to monitor SEC13 conformational changes during COPII assembly

These technologies could help address key questions about how SEC13 serves as a master regulator coordinating information flow from the genome to the proteome . Particularly valuable would be approaches that can capture the dynamic nature of SEC13's multiple roles and elucidate how it integrates signals across different cellular compartments to maintain proteostasis.

What are the critical unresolved questions about SEC13's role in human cells?

Despite significant advances, several critical questions about SEC13's role in human cells remain unresolved:

Regulatory Mechanisms: How is SEC13 expression itself regulated, and how does this regulation respond to cellular stress or developmental cues? Understanding the control mechanisms would provide insight into how SEC13 functions as a master regulator coordinating information flow through various cellular compartments .

Functional Hierarchy: Given that different cellular processes show differential sensitivity to SEC13 levels , what determines this hierarchy? Is there a programmed order in which functions are preserved or sacrificed when SEC13 availability is limited?

Temporal Coordination: How does SEC13 achieve temporal coordination between its multiple roles? Does it cycle between different protein complexes, or can it simultaneously participate in multiple processes?

Disease Relevance: Beyond its established role in CFTR regulation , how does SEC13 contribute to other human diseases involving protein trafficking or quality control defects? Are there unrecognized conditions where SEC13 dysfunction plays a causal role?

Evolutionary Conservation: How conserved are SEC13's diverse functions across species, and what does this reveal about the evolutionary importance of coordinating information flow from genome to proteome?

Therapeutic Potential: Can SEC13-dependent pathways be safely modulated for therapeutic benefit without disrupting essential cellular functions? What determines the therapeutic window for such interventions?

Addressing these questions will require integrated approaches that combine structural biology, systems biology, and clinical research. The finding that SEC13 serves as an "unanticipated master regulator" suggests that continued research may reveal additional surprising functions and connections that could fundamentally change our understanding of cellular information processing.

How might systems biology approaches enhance our understanding of SEC13's integrative functions?

Systems biology approaches offer powerful frameworks for understanding SEC13's integrative functions across cellular compartments:

Multi-scale Modeling:

Network Analysis:

  • Map the complete SEC13 interaction network across cellular compartments

  • Identify network motifs and feedback loops that enable SEC13's coordinating functions

  • Determine how information flows through SEC13-containing complexes

Quantitative Proteomics Approaches:

ApproachApplication to SEC13 ResearchExpected Insights
Protein correlation profilingMap SEC13 distribution across cellular compartmentsCompartment-specific functions
Thermal proteome profilingDetect SEC13-dependent protein stability changesEffects on protein quality control
Pulse-SILACMeasure SEC13's impact on protein turnover ratesCoordination of synthesis and degradation

Integration of Multi-omics Data:
Combining transcriptomics, proteomics, and metabolomics data can reveal how SEC13 coordinates responses across different cellular processes. This integration is particularly relevant given SEC13's role in regulating information flow from genome to proteome .

Perturbation Response Analysis:
Systematic perturbation of SEC13 levels followed by comprehensive phenotypic profiling can help decipher the rules governing its master regulatory function. The observation that different processes show differential sensitivity to SEC13 levels provides a foundation for this approach.

By employing these systems biology approaches, researchers can move beyond understanding individual functions of SEC13 to comprehending how it serves as a master regulator that integrates and coordinates information flow across cellular compartments. This holistic perspective is essential for fully appreciating SEC13's role in maintaining cellular homeostasis and its potential as a therapeutic target.

Product Science Overview

Introduction

SEC13 is a protein encoded by the SEC13 gene in humans. It belongs to the SEC13 family of WD-repeat proteins and is a crucial component of the endoplasmic reticulum and the nuclear pore complex . The protein has significant similarity to the yeast SEC13 protein, which is essential for vesicle biogenesis from the endoplasmic reticulum during protein transport .

Structure and Function

SEC13 is involved in the formation of vesicles in the COPII complex, which includes other proteins such as Sec23p, Sec24p, Sar1p, and Sec31 . The COPII vesicle budding complex was initially described in the yeast system and was shown to provide coat proteins in the early secretory pathway . In humans, SEC13 plays a similar role in vesicle formation and transport.

Biological Role

The SEC13 protein is ubiquitously expressed and participates in various cellular processes, including mRNA transport, protein transport, and intracellular protein transport . It is also involved in the positive regulation of TOR signaling, sister chromatid cohesion, and the regulation of glycolytic processes . Additionally, SEC13 is a structural component of the nuclear pore complex, contributing to the transport of molecules between the nucleus and the cytoplasm .

Genetic Information

The SEC13 gene is located on chromosome 3 in humans . It has several aliases, including D3S1231E, SEC13L1, and SEC13R . The gene has multiple protein-coding transcripts, and the protein interacts with several other proteins, indicating its involvement in complex cellular networks .

Recombinant SEC13

Recombinant SEC13 is produced using recombinant DNA technology, which involves inserting the SEC13 gene into an expression system to produce the protein in vitro. This recombinant protein can be used in various research applications, including studies on vesicle formation, protein transport, and nuclear pore complex function.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.